Correction to: The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart. (2020)

First Author: Tate M
Attributed to:  Mitochondrial oxidative damage and human diseases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s10557-019-06929-2

PubMed Identifier: 32062792

Publication URI: http://europepmc.org/abstract/MED/32062792

Type: Journal Article/Review

Volume: 34

Parent Publication: Cardiovascular drugs and therapy

Issue: 2

ISSN: 0920-3206